Albumin-bound paclitaxel

Sold as Abraxane, Pacumin

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 2
Registrations: 2

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Key Oncologics (Pty) Ltd	Abraxane	100 mg	500182	Not determined	PI PIL
Cipla Medpro (Pty) LtdCancelled	Pacumin	Not stated	520610.609	Not determined	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Abraxane EACH VIAL CONTAINS : ALBUMIN-BOUND PACLITAXEL 100,0 mg	100 mgPowder for suspension for infusion.	50018250/26/0182Approved 24 May 2024	Registered	Not determined	PI PIL
Pacumin EACH VIAL CONTAINS: ALBUMIN-BOUND PACLITAXEL 100, 0 mg	Not listed	520610.60952/26/0610.609	Cancelled	Not determined	None

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsAbraxane, Key Oncologics (Pty) Ltd Patient information leaflet (PIL)For patients and carersAbraxane, Key Oncologics (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background